Affiliated Treatment Facilities
Contact Information
Joan and Paul Rubschlager Building
1520 West Harrison Street
Chicago, IL 60607
01. Doctor Overview
Doctor Overview
Dr. Helen J. Ross is a thoracic medical oncologist specializing in patient care for mesothelioma and other chest cancers. She currently practices at RUSH MD Anderson Cancer Center in Chicago, Illinois. She performs various notable roles at this cancer center, including:
- Director of research and clinical trials
- Professor in the Department of Internal Medicine
Previously, she practiced at several prestigious cancer centers in Arizona. These centers include the Mayo Clinic and Banner MD Anderson Cancer Center.
Dr. Ross has been practicing medicine for more than 20 years. She strives to provide the best patient care and family support. She also works toward medical and professional healthcare advances, helping to develop new treatments that will improve patient survival rates and quality of life.
As part of her research, she has participated in more than 350 pieces of medical literature. Dr. Ross has authored and co-authored medical studies, book chapters and peer-reviewed medical articles. Her work has been published in prominent journals, like The Annals of Thoracic Surgery. Her areas of research that may help mesothelioma patients include:
- Chemotherapy drugs for lung conditions
- New chemotherapy combinations for peritoneal mesothelioma
- Stereotactic body radiotherapy for recurrent cancers
02. Fast Facts
Doctor Fast Facts
Main Specialty: Thoracic oncology
Other Interests & Specialties: Chemotherapy, epidemiology, immune system disorders, lung cancer, malignant mesothelioma, esophageal cancer, multimodality therapy and clinical trials.
Certifications, Awards & Accolades: American Board of Internal Medicine Certifications in Medical Oncology and Internal Medicine, eight-year recipient of America’s Top Doctors and America’s Top Doctors for Cancer, six-year recipient of Castle Connolly America’s Top Doctors and Castle Connolly America’s Top Doctors for Cancer, six-year recipient of Exceptional Women In Medicine, Top Presenters in Arizona Merit Award from Mayo School of Continuous Professional Development
Education & Experience:
- Bachelor’s Degree in Biology at UC San Diego
- Medical Degree from David Geffen School of Medicine at University of California, Los Angeles
- Fellowship in Hematology and Medical Oncology at Ronald Reagan, University of California, Los Angeles Medical Center
- Residency in Internal Medicine at Cedars-Sinai Medical Center
03. Publications
Publications
Atezolizumab before and after chemoradiation for unresectable stage iii non-small cell lung cancer: a phase ii nonrandomized controlled trial. JAMA Oncol. 2024 Jul 25;e241897.
Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma. Lung Cancer. 2014 Sep;85(3):429–34.
Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: outcomes of an expanded access program. Lung Cancer. 2007 Feb;55(2):187–94.
Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program. J Thorac Oncol. 2006 Jul;1(6):506–12.
Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clin Lung Cancer. 2005 Jul;7(1):40–6.
